Advertisement

BBV154 News

alt
Bharat Biotech has completed phase III clinical trials for intranasal Covid vaccine The firm said that 'it has proven to be safe' BBV154 has been specifically formulated to allow intranasal delivery
alt
Bharat Biotech has received approval for phase 3 clinical trials of intranasal vaccine. Intranasal vaccine can be easily administered.






Loading...
english news
NEWS ON ONE CLICK